The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy

被引:1
作者
Klimontov, V. V. [1 ]
Myakina, N. E. [1 ]
机构
[1] Sci Inst Clin & Expt Lymphol, Novosibirsk, Russia
来源
DIABETES MELLITUS | 2015年 / 18卷 / 04期
关键词
type; 2; diabetes; chronic kidney disease; glucose variability; continuous glucose monitoring; hypoglycaemia;
D O I
10.14341/DM7181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To assess the relationship of glucose variability (GV) and renal function in patients with type 2 diabetes on basal-bolus insulin therapy. Materials and methods. We observed 101 females with type 2 diabetes, aged 47-79 years, with a glomerular filtration rate (GFR) >30 mL/min/1.73 m(2). Insulin was combined with metformin in 45 of these women. The mean glucose and standard deviation, continuous overlapping net glucose action, lability index, J-index, low blood glucose index (LBGI), high blood glucose index (HBGI), M-value and mean absolute glucose (MAG) were calculated based on the results of blinded continuous glucose monitoring. The prevalence of episodes of low interstitial glucose (<3.9 and 2.8 mmol/L) of at least 20-min duration was estimated. Results. Patients with a GFR of 30-44 mL/min/1.73 m2 had significantly lower HBGI, J-index, MAG and M-value compared with those with better filtration (all p < 0.05); LBGI was not dependent on GFR. The GFR values were weakly and positively correlated with HBGI, J-index, M-value and MAG. Multiple regression analysis showed that GFR is an independent predictor of MAG (p = 0.04). No significant differences were found in the prevalence of episodes of low interstitial glucose between patients with different GFR ranges. Conclusions. GV parameters are related to renal function in type 2 diabetic women on basal-bolus insulin therapy. Patients with stage 3b chronic kidney disease have reduced GV, predominantly in the hyperglycaemic band, compared with those with better filtration.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 21 条
[1]   Insulin resistance and postprandial triglyceride levels in primary renal disease [J].
Charlesworth, JA ;
Kriketos, AD ;
Jones, JE ;
Erlich, JH ;
Campbell, LV ;
Peake, PW .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (06) :821-828
[2]   Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications [J].
Gerich, J. E. .
DIABETIC MEDICINE, 2010, 27 (02) :136-142
[3]   Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration [J].
Heller, S. R. ;
Choudhary, P. ;
Davies, C. ;
Emery, C. ;
Campbell, M. J. ;
Freeman, J. ;
Amiel, S. A. ;
Malik, R. ;
Frier, B. M. ;
Allen, K. V. ;
Zammitt, N. N. ;
Macleod, K. ;
Lonnen, K. F. ;
Kerr, D. ;
Richardson, T. ;
Hunter, S. ;
Mclaughlin, D. .
DIABETOLOGIA, 2007, 50 (06) :1140-1147
[4]   Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups [J].
Hill, Nathan R. ;
Oliver, Nick S. ;
Choudhary, Pratik ;
Levy, Jonathan C. ;
Hindmarsh, Peter ;
Matthews, David R. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (09) :921-928
[5]   Clinical application of emerging sensor technologies in diabetes management: Consensus guidelines for continuous glucose monitoring (CGM) [J].
Hirsch, Irl B. ;
Armstrong, Dana ;
Bergenstal, Richard M. ;
Buckingham, Bruce ;
Childs, Belinda P. ;
Clarke, William L. ;
Peters, Anne ;
Wolpert, Howard .
DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (04) :232-246
[6]  
Hung AM, 2011, CONTRIB NEPHROL, V171, P127, DOI 10.1159/000327177
[7]   Glycaemic variability in diabetes: a tool for assessing the quality of glycaemic control and the risk of complications [J].
Klimontov, V. V. ;
Myakina, N. E. .
DIABETES MELLITUS, 2014, 17 (02) :76-82
[8]   Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring [J].
Klimontov, V. V. ;
Tsiberkin, A., I ;
Fazullina, O. N. ;
Prudnikova, M. A. ;
Tyan, N., V ;
Konenkov, V., I .
DIABETES MELLITUS, 2014, 17 (01) :75-80
[9]   Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus [J].
Meyer, C ;
Stumvoll, M ;
Nadkarni, V ;
Dostou, J ;
Mitrakou, A ;
Gerich, J .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) :619-624
[10]   Glycemic Control in Diabetic Dialysis Patients and the Burnt-Out Diabetes Phenomenon [J].
Park, Jongha ;
Lertdumrongluk, Paungpaga ;
Molnar, Miklos Z. ;
Kovesdy, Csaba P. ;
Kalantar-Zadeh, Kamyar .
CURRENT DIABETES REPORTS, 2012, 12 (04) :432-439